M&A TRANSACTION · 2024
OPKO / BioReference Clinical Diagnostics Business acquired by Labcorp
$237.6M· 2.40x revenue
Target
OPKO / BioReference Clinical Diagnostics Business
Acquirer
Labcorp
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$100.0M
EBITDA
—
Deal Value
$237.6M
EV/EBITDA
—
Context
This $237.6M acquisition of OPKO / BioReference Clinical Diagnostics Business by Labcorp sits in the laboratory services sub-vertical. Labcorp is acquiring as a strategic buyer; see how strategic acquirers typically price laboratory services businesses on our Laboratory Services strategic buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own laboratory services
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the OPKO / BioReference Clinical Diagnostics Business acquisition.